Peter DiLaura

President and CEO

2024 - Current

Strategic Advisor

2024

Chief Business and Strategy Officer

2020 - 2024

Member of the Executive Team, responsible for all elements of company operations and strategy, including financing, corporate development and partnering, financial operations, program and portfolio management, legal, and HR. - Led financing efforts, including $265M Series B financing - Led corporate development efforts, including principal sourcing and negotiation of multi-indication discovery, development, and commercialization collaboration with Regeneron, with $75M upfront, $45M in early milestones, and 50/50 cost and profit sharing structure - Built and managed Finance, Legal, HR, and Program Management functions

Member Board of Directors

2020

Entrepreneur In Residence

2018 - 2020

Led and supported incubation efforts for multiple early company concepts.

Strategic Advisor

2017 - 2019

Advisor

2017 - 2017

President & CEO

2010 - 2016

CEO and Director of Second Genome, a South San Francisco biotechnology company developing novel drugs from microbiome science. Led the company from an early team of founders to 30 employees.

Senior Vice President

2001 - 2010

Commercial roles with increasing responsibility at Ingenuity Systems, a Bay Area systems biology company.

Vice President, Business Development

1999 - 2001

Responsible for corporate strategy, business development, and marketing activities for publicly traded life sciences e-commerce pioneer.

Consultant

1995 - 1999

Strategic consulting to clients in the pharmaceutical, biotech, medical device and diagnostic industries, focused on opportunity assessment, merger and acquisition advisory, and strategic planning.